|
PRESS RELEASES
Contacts: Anthony G. Viscogliosi, Viscogliosi Bros., LLC (212) 583-9700
ext. 101
Chris Storer, Creative Partners (203) 705-9219
VISCOGLIOSI BROS., LLC ACQUIRES FIXANO, S.A., A LEADING FRENCH ORTHOPEDICS
COMPANY
New York, NY: May 4, 2005 - Viscogliosi Bros., LLC (“VB”)
completed its acquisition of the French orthopedic company, Fixano,
S.A (“Fixano”), Bourg-en-Bresse, France. Terms of the deal
were not disclosed.
Fixano S.A. is a privately-held French orthopedic company based near
Lyon, France. The company specializes in developing, manufacturing,
and marketing technologies in orthopedics, trauma, and spine. The company
was founded by Jean-Jacques Martin in 1987, with an external fixation
product line of ring fixators and in-house manufacturing. Fixano has
long been a specialist in orthopedic and trauma devices. The company
produces a comprehensive array of products that address internal and
external fixation, spine, and joint replacement markets. In addition
to its product development efforts, Fixano also maintains an ISO 9001
manufacturing facility at its Bourg-en-Bresse headquarters.
Fixano is currently poised to provide its array of orthopedic devices
to the rest of Europe—a market currently estimated at $3.9 billion
in annual sales, and growing. France, along with Germany, and Italy,
comprise the bulk of the European orthopedics market. Fixano is in a
prime position within Europe, with an extensive distribution network
and solid surgeon relationships.
Anthony G. Viscogliosi, a Principal at VB, said: “We are extremely
excited to have the opportunity to work with Fixano and help them to
develop their entire product line. In my more than 15 years of experience
in the orthopedic marketplace, I believe Fixano has one of the broadest,
most innovate, highly indication-specific product portfolios of any
private company I have examined. We aim to continue the Fixano tradition
of managing surgeon relationships, developing innovative products, and
distributing them internationally, while we supply the company with
the augmented resources and the VB cultivated relationships that Fixano
needs to enhance its global position. I look forward to helping Fixano
build on their history of successes.”
Jean Jacques Martín, President and CEO of Fixano, said: “I
am very excited by the opportunity to combine with the VB portfolio
of companies. Fixano has traditionally grown, from both a product and
market perspective, at a rate I am pleased with, given our resources.
Now, with VB’s support, I expect we will finally realize the potential
of our surgeon innovated products.”
Marc R. Viscogliosi, a Viscogliosi Bros., LLC Principal, added, “I
am thrilled to work with Fixano’s remarkably talented management
team and their revolutionary product lines, particularly the “U”
non-fusion interspinous device. Together, our innovative products, years
of experience, deep industry knowledge and close relationships with
the world’s leading spine surgeons will continue to change the
spine world.”
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony
G. Viscogliosi in New York City in 1999, VB was the first venture capital/private
equity and merchant banking firm dedicated to the musculoskeletal/orthopedics
sector of the health care industry. Today, VB is a leading independent
firm with a mission to create, build and finance companies founded on
innovations developed by surgeons and uniquely focused on "life
changing" musculoskeletal/orthopedic technologies. VB has worldwide
surgeon, industry and trade relationships and significant financial
expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total
of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics
sector. They have pioneered innovative financial, strategic and management
initiatives for companies in the sector, from start-up, seed and development
stage all the way to exit, while helping thousands of people lead better
lives through the orthopedic and spinal products marketed and sold by
the companies they have assisted in developing and financing.
> Back to Press Releases
|
|